Experts flag risk of femur fractures from long-term bisphosphonate use
EXPERTS are again warning of the possible association between long-term use of oral bisphosphonates and the risk of atypical femur fractures. A recent letter by Dr Christian Girgis, a clinical associate lecturer at the University of Sydney, has highlighted the issue. Dr Girgis and his team reviewed 152 patients admitted to hospital with femoral fractures, with the aim of clarifying conflicting results from previous trials. Of 152 patients, 20 had atypical femur fractures. And the vast majority of these patients – 17 – were currently receiving oral bisphosphonate treatment. Most of these patients were taking ...
